DOJ Approves $69B CVS Health-Aetna Merger, With Conditions - NBC4 Washington
National & International News
The day’s top national and international news

DOJ Approves $69B CVS Health-Aetna Merger, With Conditions

Aetna announced in September it would be selling its business

    processing...

    NEWSLETTERS

    Top 4 Reasons to Go to ZooLights
    Bill Sikes/AP, File
    In this June 1, 2017, file photo, a sign stands on the campus of the Aetna headquarters in Hartford, Connecticut. The Justice Department has agreed to Aetna’s plan to sell its Medicare Part D prescription drug plan business for individuals to fellow insurer WellCare, resolving competition concerns.

    The proposed $69 billion merger between CVS Health and Aetna is getting a greenlight from the Department of Justice, with some conditions.

    The Justice Department on Wednesday approved the deal on the condition that Aetna moves ahead with its plan to sell its Medicare Part D prescription drug plan business, resolving some anti-monopoly issues.

    Aetna announced last month it'd sell the business for an undisclosed amount.

    CVS announced plans to buy Hartford, Connecticut's Aetna late last year. The deal is expected to give the Woonsocket, Rhode Island, drugstore chain a bigger role in health care, with the companies combining to manage care through CVS stores, clinics and prescription drugs.